A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 25, 2019

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Breast Cancer
Interventions
RADIATION

Radiomics on MRI

"Through extracting and analyzing a large number of features from medical imaging, radiomics has shown promising results in treatment outcome prediction for many diseases including breast cancer (45-50). UTSW physics group has developed several new radiomic approaches and radiomic features, such as a multi-objective radiomics model(51) and a new radiomic Shell feature(52). As an exploratory end point for this trial, the investigators will explore the application radiomics using pre-treatment MRI, treatment parameters and clinical characteristics as input to predict pathological response of radiation therapy (XRT) based on pathology report of surgical tissues and local recurrence."

Trial Locations (1)

75390

University of Texas Southwestern Medical Center - Dallas, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT04040569 - A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer | Biotech Hunter | Biotech Hunter